The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

The Food and Drug Administration is telling Pfizer and Moderna to expand the warning labels on their COVID-19 vaccines about the risk of a possible heart injury side effect linked to the mRNA shots, ...

The XFG variant of the severe acute respiratory syndrome coronavirus 2 as continued to spread as the U.S. heads into peak Summer travel season. (Photo by I RYU/VCG via Getty Images) There’s another ...

EDITOR’S NOTE: This story has been updated to reflect changes to US Centers for Disease Control and Prevention immunization schedules. The US Department of Health and Human Services, under Secretary ...

New COVID-19 variant XFG has firmly positioned itself as the predominant strain in the United States as cases continue to crop up nationwide. Some regions of the U.S. are experiencing higher rates of ...

As the respiratory illness season begins, COVID cases have remained relatively under control in the United States into the beginning of fall. While the United States by and large is experiencing ...

The US Food and Drug Administration approved updated Covid-19 vaccines Wednesday, but for a limited group: adults 65 and older, and younger people who are at higher risk from Covid-19. “FDA has now ...

COVID-19 variant BA.3.2 or "cicada" is not widely circulating in the U.S. yet, but based on trends in Europe, it may become more prominent. Most evidence comes from laboratory data, but there are no ...

Coronavirus cases may surge in the coming weeks, as they have every summer since the pandemic began five years ago, experts said. Getting vaccinated, masking, improving air quality and staying away ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...